COMBINATION THERAPY USING ACTIVE IMMUNOTHERAPY
The present invention relates to methods of treating cancer in a mammal comprising administering to the mammal a combination therapy comprising a vaccine and a multi-kinase inhibitor, wherein the vaccine comprises an isolated tumor associated peptide having the ability to bind to a molecule of the h...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
22.01.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to methods of treating cancer in a mammal comprising administering to the mammal a combination therapy comprising a vaccine and a multi-kinase inhibitor, wherein the vaccine comprises an isolated tumor associated peptide having the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I or class-II. Preferably the multi-kinase inhibitor is sunitinib malate and/or sorafenib tosylate or a pharmaceutically acceptable salt thereof. |
---|---|
Bibliography: | Application Number: US201414453410 |